Northern Trust’s Zai Lab ZLAB Stock Holding History

Northern Trust’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$484K	Sell	25,709 -70,733	-73%	-$1.31M	﹤0.01%	3629
2025 Q4	$1.7M	Sell	96,442 -49,561	-34%	-$1.16M	﹤0.01%	3093
2025 Q3	$4.95M	Sell	146,003 -14	-0%	-$482	﹤0.01%	2512
2025 Q2	$5.11M	Sell	146,017 -16,681	-10%	-$548K	﹤0.01%	2449
2025 Q1	$5.88M	Buy	162,698 +113,333	+230%	+$3.49M	﹤0.01%	2336
2024 Q4	$1.29M	Buy	49,365 +26,700	+118%	+$741K	﹤0.01%	3268
2024 Q3	$547K	Buy	22,665 +141	+0.6%	+$2.67K	﹤0.01%	3558
2024 Q2	$390K	Buy	22,524 +2,036	+10%	+$35.8K	﹤0.01%	3599
2024 Q1	$328K	Sell	20,488 -1,307	-6%	-$27.5K	﹤0.01%	3714
2023 Q4	$596K	Buy	21,795 +2,930	+16%	+$77.3K	﹤0.01%	3485
2023 Q3	$459K	Sell	18,865 -114	-0.6%	-$3.04K	﹤0.01%	3545
2023 Q2	$526K	Sell	18,979 -264,741	-93%	-$8.66M	﹤0.01%	3533
2023 Q1	$9.44M	Buy	283,720 +69,457	+32%	+$2.67M	﹤0.01%	2055
2022 Q4	$6.58M	Sell	214,263 -11,097	-5%	-$350K	﹤0.01%	2302
2022 Q3	$7.71M	Buy	225,360 +14,211	+7%	+$608K	﹤0.01%	2174
2022 Q2	$7.32M	Buy	211,149 +30,393	+17%	+$1.07M	﹤0.01%	2258
2022 Q1	$7.95M	Sell	180,756 -5,112	-3%	-$247K	﹤0.01%	2294
2021 Q4	$11.7M	Sell	185,868 -17,123	-8%	-$1.45M	﹤0.01%	2125
2021 Q3	$21.4M	Sell	202,991 -135,880	-40%	-$19.5M	﹤0.01%	1762
2021 Q2	$60M	Buy	338,871 +20,395	+6%	+$3.28M	0.01%	986
2021 Q1	$42.5M	Buy	318,476 +23,171	+8%	+$3.59M	0.01%	1246
2020 Q4	$40M	Buy	295,305 +9,176	+3%	+$934K	0.01%	1251
2020 Q3	$23.8M	Buy	286,129 +78,344	+38%	+$6.29M	0.01%	1492
2020 Q2	$17.1M	Buy	207,785 +110,955	+115%	+$7.51M	﹤0.01%	1753
2020 Q1	$4.99M	Buy	96,830 +50,692	+110%	+$2.64M	﹤0.01%	2305
2019 Q4	$1.92M	Buy	46,138 +2,122	+5%	+$78.3K	﹤0.01%	3149
2019 Q3	$1.42M	Sell	44,016 -44	-0.1%	-$1.51K	﹤0.01%	3270
2019 Q2	$1.54M	Buy	44,060 +13,384	+44%	+$394K	﹤0.01%	3197
2019 Q1	$905K	Buy	30,676 +2,332	+8%	+$63.8K	﹤0.01%	3394
2018 Q4	$658K	Sell	28,344 -61	-0.2%	-$1.13K	﹤0.01%	3489
2018 Q3	$553K	Buy	28,405 +18,766	+195%	+$407K	﹤0.01%	3612
2018 Q2	$224K	Buy	+9,639	New	+$208K	﹤0.01%	3821

Other funds holding ZLAB

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Northern Trust's ZLAB Position: Q1 2026 in Review

Northern Trust reduced its Zai Lab (ZLAB) stake by 73% in Q1 2026, selling an estimated $1.31M and leaving 25,709 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #3629.

Northern Trust first reported a position in ZLAB in Q2 2018 and has held it in 32 quarters since. The position peaked at $60M in Q2 2021. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

Northern Trust held 25,709 shares of Zai Lab worth $484K as of Q1 2026.
Northern Trust sold 70,733 Zai Lab shares in Q1 2026, an estimated $1.31M.
Zai Lab made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3629 holding.
Northern Trust first reported a position in Zai Lab in Q2 2018 and has held it in 32 quarters since.
Northern Trust's Zai Lab position peaked at $60M in Q2 2021.
99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.